Autologous blood procurement in the surgical setting: Lessons learned in the last 10 years

Vox Sanguinis

Volumn 71, Issue 3, 1996, Pages 133-141

  Goodnough, Lawrence Tim ^a,b   Monk, Terri G ^a,b   Brecher, Mark E ^c,d  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD AUTOTRANSFUSION; BLOOD DONOR; BLOOD STORAGE; COST EFFECTIVENESS ANALYSIS; ELECTIVE SURGERY; HEMODILUTION; HUMAN; PHLEBOTOMY; PRIORITY JOURNAL; REVIEW;

EID: 0029801653     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1423-0410.1996.7130133.x     Document Type: Review

References (75)

1. Roche JK, Stengle JM: Open heart surgery and the demand for blood. JAMA 1973;225:1516-1521.
2. Toy PTCY, Strauss R, Stehling L, et al: Predeposit autologous blood for elective surgery: A multicenter study. N Engl J Med 1987;316: 517-520.
3. Kruskall MS, Glazer EE, Leonard SS, et al: Utilization and effectiveness of a hospital autologous preoperative blood donor program. Transfusion 1986;26:335-340.
4. Surgenor DM, Wallace EL, Hae SH, Chapman RH: Collection and transfusion of blood in the United States, 1982-1988. N Engl J Med 1990; 332:1646-1651.
5. Wallace EL, Churchill WH, Surgenor DM, An J, Cho G, McQuirk S, Murphy L: Collection and transfusion of blood and blood components in the United States, 1992. Transfusion.
6. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. N Engl J Med 1996;334:1685-1690.
7. Goodnough LT, Bodner MS, Martin JW. Blood transfusion and blood conservation: Cost and utilization issues. Aller J Med Qual 1994;9: 172-183.
8. Goodnough LT: The implications of cost-effectiveness for autologous blood procurement. Arch Pathol Lab Med 1994;118:471-472.
9. Goodnough LT, Shafron D, Marcus RE: The impact of preoperative autologous blood donation on orthopaedic surgical practice. Vox Sang 1990;59:65-69.
10. Goodnough LT, Grishaber JE, Birkmeyer JD, Monk TG, Catalona WJ: Efficacy and cost-effectiveness of autologous blood predeposit in patients undergoing radical prostatectomy procedures. Urology 1994;44:226-231.
11. British Committee for Standards in Haematology Blood Transfusion Task Force: Guidelines for autologous donation: Preoperative autologous donation. Transfus Med 1993;3:307-316.
12. NHLBI: Transfusion alert: Use of autologous blood. Transfusion 1995;35:703-711.
13. Mintz PD, Nordine RB, Henry JB, Web WR: Expected hemotherapy in elective surgery. NY State J Med 1976;76:532-537.
14. Renner SW, Howanitz PJ, Bachner P: Preoperative autologous blood donation in 612 hospitals. Arch Pathol Lab Med 1992;116:613-619.
15. Surgenor DM, Churchill WH, Wallace EL, et al: Determinants of red cell, platelet, plasma, and cryoprecipate transfusions during coronary artery bypass graft surgery. Transfusion in press.
16. Goodnough LT, Vizmeg K, Verbrugge D: The impact of autologous blood ordering and blood procurement practices on allogeneic blood exposure in elective orthopedic surgery patients. Am J Clin Pathol 1994;101:354-357.
17. Toy PTCY, Kaplan EB, McVay PA, et al: Blood loss and replacement in total hip arthroplasty: A multicenter study. Transfusion 1992;32:63-67.
18. Goodnough LT, Vizmeg K, Marcus RE: Blood lost and blood transfused in patients undergoing elective orthopedic operation. Surg Gynecol Obstet 1993;176:235-240.
19. Goodnough LT, Soegiarso RW, Geha AS: Blood lost and blood transfused in patients undergoing elective coronary artery bypass: Implications for blood conservation strategies. Surg Gynecol Obstet 1993;177:345-351.
20. Kickler TS, Spivak JL: Effect of repeated whole blood donations on serum immunoreactive erythropoietin levels in autologous donors. JAMA 1988;260:65-67.
21. Goodnough LT, Brittenham G: Limitations of the erythroppietic response to serial phlebotomy: Implications for autologous blood donor programs. Lab Clin Med 1990;115:28-35.
22. Cohen JA, Brecher ME: Preoperative autologous blood donation: Benefit or detriment? A mathematical analysis. Transfusion 1995;35:640-644.
23. Goodnough LT, Price TH, Parvin CA, et al: Erythropoietin response to anaemia is not altered by surgical or recombinant human erythropoietin therapy. Br J Haematol 1994;87:695-699.
24. Goodnough LT, Bravo J, Hsenh Y, Keating L, Brittenham GM: Red blood cell volume in autologous and homologous blood units: Implications for risk/benefit assessment for autologous blood 'crossover' and directed blood transfusions. Transfusion 1989;29:821-822.
25. Goodnough LT, Price TH, Rudnick S, Soegiarso RW: Preoperative red blood cell production in patients undergoing aggressive autologous blood phlebotomy with and without erythropoietin therapy. Transfusion 1992;32:441-445.
26. Goodnough LT, Price TH, Parvin CA: The endogeneous erythropoietin response and the erythropoietic response to blood loss anemia: The effects of gender and age. J Lab Clin Med 1995;126:57-64.
27. Goodnough LT, Rudnick S, Price TH, et al: Increased collection of autologous blood preoperatively with recombinant human erythropoietin therapy. N Engl J Med 1989;321:1163-1167.
28. Goodnough LT, Price TH, Friedman KD, et al: A phase III trial of recombinant human erythropoietin therapy in non-anemic orthopaedic patients subjected to aggressive autologous blood phlebotomy: Dose, response, toxicity and efficacy. Transfusion 1994;34:66-71.
29. Price TH, Goodnough LT, Vogler W, et al: The effect of recombinant erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits. Transfusion 36:29-36.
30. Mercuriali F, Zanella A, Barosi G, et al: Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patients. Transfusion 1993;33:55-60.
31. Mercuriali F, Gualtieri G, Singaglia L, et al: Use of recombinant human erythropoietin to assist autologous blood donation by anemic rheumatoid arthritis patients undergoing major orthopaedic surgery. Transfusion 1994;34:501-506.
32. Birkmeyer JD, Goodnough LT, AuBuchon JP, Noordsy PG, Littenberg B: The cost-effectiveness of preoperative autologous blood donation for total hip and knee replacement. Transfusion 1993;33:544-550.
33. Goodnough LT, Saha P, Hirschler N, Yomtovian R: Autologous blood donation in non-orthopaedic surgery as a blood conservation strategy. Vox Sang 1992;63:96-101.
34. Combs CA, Murphy EL, Laros RK: Cost-benefit analysis of autologous blood donation in obstetrics. Obstet Gynecol 1992;80:621-625.
35. Birkmeyer JD, AuBuchon JR Littenberg B, et al: The costs and benefits of preoperative autologous blood donation in elective coronary bypass surgery. Ann Thorac Surg 1994;57:161-169.
36. Etchason J, Petz L, Keeler E, et al: Cost-effectiveness of autologous blood donations. N Engl J Med 1995;332:719-724.
37. Menitove JE: The recent emphasis on good manufacturing practices and the pharmaceutical manufacturing approach damages blood banking and transfusion medicine as medical care activities. Con. Transfusion 1993;94:439-442.
38. Kruskall MS, Yomtovian R, Dzik WH, Friedman KD, Umlas J: On improving the cost-effectiveness of autologous blood transfusion practices. Transfusion 1994;34:259-264.
39. Miller WV: Blood banks should use good manufacturing practices and the pharmaceutical manufacturing approach. Pro. Transfusion 1993;94:435-438.
40. Popovsky MA, Whitaker B, Arnold NL: Severe outcomes of allogeneic and autologous blood donation: Frequency and characterization. Transfusion 1995;35:734-737.
41. Goodnough LT, Monk TG: Evolving concepts in autologous blood procurement in elective surgery. Am J Med, in press.
42. Owings DV, Kruskall MS, Thurer RL, Donovan LM: Autologous blood donations prior to elective cardiac surgery. JAMA 1989;262:1963-1968.
43. Dzik WH, Fleisher AG, Ciavarella D, et al: Safety and efficacy of autologous blood donation before elective aortic value operation. Ann Thorac Surg 1992;54:1177-1181.
44. Zuck TF: Legal liability for transfusion injury in the acquired immunodeficiency syndrome era. Arch Pathol Lab Med 1990;114:309-315.
45. Bierig JR: Legal issues for blood banks. Arch Pathol Lab Med 1994;118:442-453.
46. Goodnough LT, Marcus RE: Blood transfusion in elective orthopedic surgery: Issues related to informed consent. Perspect Orthop 1991;2: 104-118.
47. Silberstein LE, Kruskall MS, Stehling LC, et al: Strategies for the review of transfusion practices. JAMA 1989;262:1993-1997.
48. Sazama K: Report of 355 transfusion associated deaths: 1976 through 1985. Transfusion 1990; 30:583-590.
49. Stehling L, Luban NLC, Anderson KC, et al: Guidelines for blood utilization review. Transfusion 1994;34:438-448.
50. Welch GH, Meehan K, Goodnough LT: Prudent strategies for elective red cell transfusion. Ann Intern Med 1992;116:393-403.
51. Messmer K, Kreimeier M, Intagliett A: Present state of intentional hemodilution. Eur Surg Res 1986;18:254-263.
52. Goodnough LT, Grishaber J, Monk TG, Catalona WJ: Acute preoperative hemodilution in patients undergoing radical prostatectomy: A case study analysis of efficacy. Anesth Analg 1994;78:932-937.
53. Brecher ME, Rosenfeld M: Mathematical and computer modeling of acute normovolemic hemodilution. Transfusion 1994;34:176-179.
54. Weiskopf RB: Mathematical analysis of isovolemic hemodilution indicates that it can decrease the need for allogeneic blood transfusion. Transfusion 1995;35:37-41.
55. Monk TG, Goodnough LT, Birkmeyer JD, Brecher ME, Catalona WJ: Acute normovolemic hemodilution is a cost-effective alternative to preoperative autologous donation in patients undergoing radical retropubic prostatectomy. Transfusion 1995;35:559-565.
56. Winslow RM: Blood substitutes. Current status. Transfusion 1989;29:753-754.
57. Ray JM, Flynn JC, Bierman AH: Erythrocyte survival following intraoperative autotransfusion in spinal surgery: An in vivo comparative study and 5-year update. Spine 1986;11:879-882.
58. Horst HM, Dlugos S, Fath JJ, et al: Coagulopathy and intraoperative blood salvage. J Trauma 1992;32:646-653.
59. Bell K, Stott K, Sinclair CJ, Walker WS, Gillon J: A controlled trial of intraoperative autologous transfusion in cardiothoracic surgery measuring effect on transfusion requirements and clinical outcome. Transfusion Med 1992;2: 295-300.
60. Solomon MD, Rutledge ML, Kane LE, Yawn DH: Cost comparison of intraoperative autologous versus homologous transfusion. Transfusion 1988;28:379-382.
61. Bovill DF, Moulton CW, Jackson WS, Jensen JK, Barcellos RW: The efficacy of intraoperative autologous transfusion in major orthopaedic surgery: A regression analysis. Orthopaedics 1986;9:1403-1407.
62. Semkiew LB, Schurman OJ, Goodman SB, Woolson ST: Postoperative blood salvage using the cell saver after total joint arthroplasty. J Bone Joint Surg 1989;71A:823-827.
63. Flynn JC, Price CT, Zink WP: The third step of total autologous blood transfusion in scoliosis surgery. Spine 1991;16:328-329.
64. Faris PM, Ritter MA, Keating EM, Valeri CR: Unwashed filtered shed blood collected after knee and hip arthroplasties. J Bone Joint Surg 1991;73A:1169-1177.
65. Martin JW, Whiteside LA, Milliano MT, Reedy ME: Postoperative blood retrieval and transfusion in cementless total knee arthroplasty. J Arthroplasty 1992;7:205-210.
66. Ayers DC, Murray DG, Duerr DM: Blood salvage after total hip arthroplasty. J Bone Joint Surg 1995;77A:1347-1351.
67. Goodnough LT, Verbrugge D, Marcus RE: The relationship between hematocrit, blood lost, and blood transfused in total knee replacement: Implications for postoperative blood salvage and reinfusion. Amer J Knee Surg 1995;8:83-87.
68. Mylod AG, France MP, Muser DE, Parsons JR: Perioperative blood loss associated with total knee arthroplasty: A comparison of procedures performed with and without cementing. J Bone Joint Surg 1990;72A:110-112.
69. McCarthy JC, Turner RH, Reuten JJ, Valeri CR, Ragno GM, Korten KW: The effect of cell washing on the quality of shed blood in major reconstructive surgery. Orthop Trans 1992;16: 484.
70. Clements DH, Sculco TP, Burke SW, Mayer K, Levine DB: Salvage and reinfusion of postoperative sanguineous wound drainage. J Bone Joint Surg 1992;74A:646-651.
71. Woda R, Tetzlaff JE: Upper airway oedema following autologous blood transfusion from a wound drainage system. Can J Anaesth 1992; 39:290-292.
72. Blevins FT, Shaw B, Valeri RC, Kasser J, Hall J: Reinfusion of shed blood after orthopaedic procedures in children and adolescents. J Bone Joint Surg 1993;75A:363-371.
73. Trammell TR, Fisher D, Brueckmann RF, Haines N: Closed wound drainage systems: The Solcotrans Plus versus the Stryker-CBC Constavac. Orthop Rev 1991;20:536-542.
74. Gannon DM, Lombardi AV, Mallory TH, Vaughn BK, Finney CR, Niemeryk S: An evaluation of the efficacy of postoperative blood salvage after total joint arthroplasty: A prospective, randomized trial. J Arthroplasty 1991;6: 109-114.
75. Slagis SV, Benjamin JB, Volz RG, Giordano GF: Postoperative blood salvage in total hip and knee arthroplasty: A Randomized controlled trial. J Bone Joint Surg 1991;73B:591-594.